ACV01
99 years and younger
All genders
A randomized, multi-site, adaptive, open-label clinical trial to determine whether autoimmune disease pts who receive the alternate vaccine for their COVID booster vaccine [RNA then vector-based or vice versa] have a better increase in anti-COVID-19 antibody response (Spike) compared to those who receive the same vaccine booster as their initial …